Arlington, MA, United States of America

Suvi Aivio

This inventor holds 9 USPTO granted patents and 12 published patent applications. Top assignee: Cellino Biotech, Inc.. Active years: 2023-2025.

USPTO Granted Patents = 9 

% Patents Active = 100.0

Average Co-Inventor Count = 13.1

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Suvi Aivio Revolutionizes Cell Culture Automation

Introduction:

Suvi Aivio, based in Arlington, MA (US), is a prolific inventor with a notable track record in automated cell culture systems. With five patents to his name, Aivio has been making waves in the field of biotechnology.

Latest Patents:

Among Aivio's most recent patents is the groundbreaking innovation in platforms and systems for automated cell culture. These patents showcase a cell culture system that integrates advanced imaging, computing, and editing subsystems to streamline the cell culture process and enhance the production of output cell products.

Career Highlights:

Aivio is a key figure at Cellino Biotech, Inc., a leading biotechnology company at the forefront of cell culture technology. His expertise and innovative solutions have significantly contributed to the advancement of automated cell culture systems within the industry.

Collaborations:

Aivio collaborates closely with accomplished colleagues at Cellino Biotech, Inc., including Matthias Wagner and Mariangela Amenduni. Together, they form a dynamic team dedicated to pushing the boundaries of cell culture automation and driving innovation in biotechnology.

Conclusion:

In conclusion, Suvi Aivio's inventive spirit and dedication to advancing cell culture automation have positioned him as a trailblazer in the field. His contributions, exemplified by a series of patents and collaborations with industry experts, underscore his commitment to driving progress and innovation in biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…